Innoviva
INVA
99 hedge funds and large institutions have $992M invested in Innoviva in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 34 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
15% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $908K
6% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 32
1% less capital invested
Capital invested by funds: $1B → $992M (-$9.7M)
17% less funds holding
Funds holding: 119 → 99 (-20)
59% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$21.3M |
| 2 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$7.33M |
| 3 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$4.91M |
| 4 |
CC
Clearline Capital
New York
|
+$4.08M |
| 5 |
GL
GLG LLC
New York
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Americafirst Capital Management
Roseville,
California
|
-$280M |
| 2 |
PC
Perry Capital
New York
|
-$18M |
| 3 |
First Eagle Investment Management
New York
|
-$12.9M |
| 4 |
State Street
Boston,
Massachusetts
|
-$10M |
| 5 |
O
OppenheimerFunds
New York
|
-$6.5M |
INVA Hedge Fund Activity: Q4 2015 in Review
99 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2015, worth a combined $992M — down 0.97% from $1B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of INVA and 14 opened new positions — a net loss of 20 holders — while 32 trimmed existing stakes and 34 added.
The largest buyer was PFM Health Sciences, opening a new position worth an estimated $21.3M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $280M sold.
- 99 institutional investors held Innoviva (INVA) as of Q4 2015, down from 119 in Q3 2015.
- Funds reported $992M of Innoviva stock for Q4 2015, down 0.97% quarter-over-quarter.
- 14 funds opened new Innoviva positions in Q4 2015 and 34 closed out, a net change of -20 holders.
- The largest Innoviva buyer in Q4 2015 was PFM Health Sciences, an estimated $21.3M added.
- The largest Innoviva seller in Q4 2015 was Americafirst Capital Management, an estimated $280M sold.
Based on aggregated 13F filings for Q4 2015.